List of insiders holdings for Emergent BioSolutions Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | El-Hibri Fuad Director | 2021-12-07 21:10:11 | 1,136,971 3,706,442 | 4,843,413 | Form 4 |
| 2 | Intervac L.L.C. 10% Owner | 2012-09-20 20:20:01 | 4,494,250 0 | 4,494,250 | Form 4 |
| 3 | Microscience Investments LTD Member of 13(d) group 10% Owner | 2007-03-16 14:18:24 | 3,636,801 0 | 3,636,801 | Form 13G |
| 4 | BIOPHARM L.L.C. 10% Owner | 2010-06-01 16:12:28 | 2,965,043 0 | 2,965,043 | Form 4 |
| 5 | Myers Robert Calvin Member 13(d) group owning >10% | 2007-02-14 12:43:52 | 2,394,045 0 | 2,394,045 | Form 13G |
| 6 | Biovac L.L.C. 13(d) group member, owns > 10% | 2007-02-14 12:30:52 | 1,599,155 0 | 1,599,155 | Form 13G |
| 7 | JP MORGAN PARTNERS BHCA LP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P JPMP MASTER FUND MANAGER L P JPMP GLOBAL INVESTORS L P JPMP CAPITAL CORP Member of 13(d) group | 2007-03-19 11:32:58 | 1,454,418 0 | 1,454,418 | Form 3 |
| 8 | Biologika L.L.C. Member 13(d) group owning >10% | 2008-06-06 18:11:33 | 1,399,764 0 | 1,399,764 | Form 4 |
| 9 | Michigan Biologic Products Inc. Member 13(d) group owning >10% | 2008-03-28 20:17:57 | 1,269,390 0 | 1,269,390 | Form 4 |
| 10 | Kramer Robert President and CEO | 2023-06-13 21:20:24 | 1,041,110 0 | 1,041,110 | Form 4 |
| 11 | ADVENT PRIVATE EQUITY FUND III A LTD PARTNERSHIP Member of 13(d) Group | 2007-06-29 17:08:51 | 925,537 0 | 925,537 | Form 13G |
| 12 | Intervac Management L.L.C. 13(d) group member, owns > 10% | 2007-02-14 12:39:25 | 719,275 0 | 719,275 | Form 13G |
| 13 | ARPI L.L.C. 13(d) group member, owns > 10% | 2007-02-14 12:20:25 | 658,254 0 | 658,254 | Form 13G |
| 14 | Mulligan Seamus Director | 2019-03-21 16:18:12 | 56,141 545,590 | 601,731 | Form 4 |
| 15 | Merlin General Partner II LTD (as General Partner of the Merlin Biosciences Fund L.P.) Member of 13(d) group | 2007-03-12 19:21:48 | 498,722 0 | 498,722 | Form 3 |
| 16 | PAPA JOSEPH C President and CEO | 2025-05-15 16:02:40 | 342,500 0 | 342,500 | Form 4 |
| 17 | Havey Adam EVP, Business Operations | 2023-06-13 21:20:59 | 336,304 0 | 336,304 | Form 4 |
| 18 | LINDAHL RICHARD S EVP, Chief Financial Officer | 2025-10-17 16:02:38 | 291,497 0 | 291,497 | Form 4 |
| 19 | ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIP Member of 13(d) Group | 2007-03-12 19:58:34 | 229,497 0 | 229,497 | Form 3 |
| 20 | Lowry Simon C SVP, R&D, CMO | 2025-03-10 16:17:54 | 194,981 0 | 194,981 | Form 4 |
| 21 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | 2024-07-12 16:33:12 | 186,382 0 | 186,382 | Form 4 |
| 22 | SULLIVAN LOUIS W Director | 2025-05-02 20:30:17 | 180,670 0 | 180,670 | Form 4 |
| 23 | Fowler Neal Franklin Director | 2025-05-02 20:31:22 | 177,075 0 | 177,075 | Form 4 |
| 24 | Harsanyi Zsolt Chairman | 2025-05-02 20:30:39 | 165,304 0 | 165,304 | Form 4 |
| 25 | Perl Jessica SVP, General Counsel, Corp Sec | 2025-03-10 16:18:27 | 164,332 0 | 164,332 | Form 4 |
| 26 | Richard Ronald Director | 2025-05-02 20:31:43 | 147,089 0 | 147,089 | Form 4 |
| 27 | Abdun-Nabi Daniel CEO | 2019-03-04 18:39:36 | 142,617 1,936 | 144,553 | Form 4 |
| 28 | Glessner Coleen EVP, Quality & Ethics, and CPL | 2025-10-16 16:21:21 | 144,319 0 | 144,319 | Form 4 |
| 29 | White Marvin L Director | 2025-05-02 20:31:33 | 130,067 0 | 130,067 | Form 4 |
| 30 | ADVENT PRIVATE EQUITY FUND III D LTD PARTNERSHIP Member if a 13(d) Group | 2007-03-12 20:00:49 | 125,921 0 | 125,921 | Form 3 |
| 31 | DeGolyer Donald W Director | 2025-11-12 16:13:07 | 119,858 0 | 119,858 | Form 4 |
| 32 | Arcuri Edward COO | 2007-05-10 11:04:35 | 115,083 0 | 115,083 | Form 4 |
| 33 | Hartzel William SVP, Bioservices | 2025-11-13 16:01:27 | 103,082 0 | 103,082 | Form 4 |
| 34 | Dayal Sujata Tyagi Director | 2025-11-10 16:09:22 | 88,980 0 | 88,980 | Form 4 |
| 35 | SARAN ATUL EVP, Chief Strat & Dev Officer | 2023-03-02 14:43:12 | 86,645 0 | 86,645 | Form 4 |
| 36 | Katkin Keith Director | 2025-05-28 16:08:23 | 86,431 0 | 86,431 | Form 4 |
| 37 | Williams Paul Anthony SVP, Products Business | 2025-06-10 16:12:27 | 85,871 0 | 85,871 | Form 4 |
| 38 | Zoon Kathryn C Director | 2025-08-18 16:33:31 | 71,799 0 | 71,799 | Form 4 |
| 39 | ADVENT PRIVATE EQUITY FUND III C LTD PARTNERSHIP Member of 13(d) Group | 2007-03-12 19:59:49 | 64,018 0 | 64,018 | Form 3 |
| 40 | Strei Katherine EVP, Chief HR Officer | 2023-03-02 14:42:23 | 62,824 0 | 62,824 | Form 4 |
| 41 | Hauer Jerome M Director | 2023-05-30 19:08:39 | 57,508 0 | 57,508 | Form 4 |
| 42 | JOULWAN GEORGE A Director | 2022-05-31 16:20:57 | 40,244 0 | 40,244 | Form 4 |
| 43 | Keese Kyle EVP, BioSciences Division | 2011-03-17 15:31:43 | 39,954 0 | 39,954 | Form 4 |
| 44 | Elsey R Don Chief Financial Officer | 2012-03-16 15:06:13 | 38,914 0 | 38,914 | Form 4 |
| 45 | Emergent BioSolutions Inc. Sean Kirk, EVP, Manufacturing | 2019-06-03 21:13:43 | 36,624 0 | 36,624 | Form 3 |
| 46 | Niederhuber John Director | 2016-05-23 08:39:36 | 30,300 0 | 30,300 | Form 4/A |
| 47 | Merlin General Partner II LTD (as Managing Partner of the Merlin Biosciences Fund Gbr) Member of 13(d) group | 2007-03-12 19:19:19 | 29,972 0 | 29,972 | Form 3 |
| 48 | Chatfield Steven EVP, BioSciences | 2013-03-18 14:11:13 | 28,000 0 | 28,000 | Form 4 |
| 49 | Esposito Denise CLO | 2009-03-12 14:38:00 | 27,300 0 | 27,300 | Form 4 |
| 50 | Labinger Barry EVP, Biosciences Div. | 2015-11-17 17:15:40 | 25,182 0 | 25,182 | Form 4 |
| 51 | Bailey Sue Director | 2021-03-08 18:30:56 | 24,427 0 | 24,427 | Form 4 |
| 52 | ADVENT PRIVATE EQUITY FUND III GMBH & CO KG Member of 13(d) Group | 2007-03-12 20:08:22 | 18,118 0 | 18,118 | Form 3 |
| 53 | Kirk Sean EVP, Manufacturing & Tech Ops | 2021-04-01 18:54:16 | 17,776 0 | 17,776 | Form 4 |
| 54 | ADVENT PRIVATE EQUITY FUND III AFFILIATES Member of 13 (d) Group | 2007-03-12 20:01:49 | 15,098 0 | 15,098 | Form 3 |
| 55 | ALLBAUGH JOE M Director | 2008-05-23 10:13:49 | 14,400 0 | 14,400 | Form 4 |
| 56 | Malik Shahzad Director | 2007-06-18 19:15:12 | 14,400 0 | 14,400 | Form 4 |
| 57 | LOCKHART STEPHEN SVP Product Development | 2010-11-16 15:13:11 | 12,813 0 | 12,813 | Form 4 |
| 58 | Smith Karen L. EVP, Chief Medical Officer | 2021-05-11 16:30:11 | 11,888 0 | 11,888 | Form 4 |
| 59 | ADVENT MANAGEMENT III L P Member of 13(d) Group | 2007-03-12 20:07:21 | 4,530 0 | 4,530 | Form 3 |
| 60 | Zink Thomas SVP & CMO | 2007-05-21 15:41:58 | 1000 0 | 1000 | Form 4 |
| 61 | Gibellini Mauro SVP, Corporate Dev. | 2007-06-06 15:10:32 | 0 0 | 0 | Form 4 |
| 62 | APAX EUROPE IV GP CO LTD Member of 13(d) group | 2008-10-17 11:12:09 | 0 0 | 0 | Form 13G |
| 63 | MILLER H HAYWOOD III Interim CEO | 2023-07-18 18:22:14 | 0 0 | 0 | Form 3 |